focus -WSS

focus

author：leisure time 2025-10-01 12:11:44 - browse：65

Portrait of Stacy Sanders -- health policy coverage from STAT — Stacy Sanders, the first-ever chief competition officer for HHS. Courtesy Department of Health and Human Services

The Department of Health and Human Services will name Stacy Sanders as its new chief competition officer, the agency announced Monday. The new position was recently created as part of an administration crackdown on corporate greed in health care.

“We know that increased competition in the marketplace is a good deal for the American people,” Sanders said in a statement. “I look forward to supporting the Biden-Harris Administration’s efforts to increase competition in health care and lower costs, helping build on steps the Administration has already taken as well as identify opportunities to further spur innovation.”

As chief competition officer, Sanders will look for ways the health department can promote competition in health care markets. She will also work with the Federal Trade Commission and the Department of Justice to develop new policy initiatives to address consolidation, and coordinate data-sharing and reciprocal training programs with the other two agencies. The FTC and DOJ are also getting new health care counsel positions to lead these efforts, the administration announced in December.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： European regulators recommend Amylyx's ALS drug be rejected

focus

WSS

How should state employee insurance handle Wegovy?

A revolution in caring for preterm infants

Phenylephrine and the overlooked value of the placebo effect

AI can decode, harness the power of the humane immune system

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

Eight reasons why you should get an updated Covid vaccine

entertainment

focus

focus

In Memoriam: Notable people who died in 2023

STAT Readout: Today's biotech news includes Sana and Amylyx

George Santos makes 1st court appearance after pleading not guilty to 13 counts

How clinical AI models' predictive power can degrade over time

Dobbs anniversary: the lost opportunity of abortion as health care

Massive project maps cells in human brain in unprecedented detail

Heart attack and stroke risk calculators need revising

FDA rejects Alnylam's heart disease treatment over insufficient data

Drug repurposing or repositioning? The language matters

FDA panel signals lack of confidence in Amgen cancer drug data

leisure time

Readout LOUD podcast: Merger Mondays, Ozempic panic

A Q&A with the global head of Boehringer Ingelheim's innovation unit

Takeaways from AdvaMed, the largest medical devices conference

Medicare to cover more brain scans related to Alzheimer’s drugs

Nick Jonas talks about managing diabetes along with his career

Was Amgen transparent enough on FDA's concern on cancer drug?

explore

focus

focus

Wikipedia